A Pilot Study of EZN-2968, an Antisense Oligonucleotide Inhibitor of HIF-1alpha, in Adults With Advanced Solid Tumors With Liver Metastases
Clinical trial NCT01120288 · COMPLETED
Trial details
- NCT number
- NCT01120288
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-29
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.